Penserra Capital Management LLC Summit Therapeutics Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.45 - $5.64 $5,451 - $12,549	-2,225 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.83 - $8.27 $48 - $82	10 Added 0.45%	2,225 $11,000
Q2 2021 Aug 12, 2021	BUY	$5.15 - $8.46 $1,596 - $2,622	310 Added 16.27%	2,215 $16,000
Q1 2021 May 13, 2021	SELL	$5.17 - $11.19 $672 - $1,454	-130 Reduced 6.39%	1,905 $11,000
Q4 2020 Feb 12, 2021	BUY	$3.25 - $6.0 $6,613 - $12,210	2,035 New	2,035 $9,000

233

83.1M

1.66M

2.56M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.58B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.